Please note: This event has been postponed and is now planned to take place in 2021. This page will be updated as soon as we have more details, and we will also contact booked delegates directly with this information. We apologise for any inconvenience this may have caused.
Jointly organised with Action Against Age-related Macular Degeneration (AAAMD) this meeting will hear from people living age-related macular degeneration (AMD) condition and from experts who work with people with AMD.
AMD is one of the leading causes of blindness in the world. Around 10 million people have late-stage AMD globally. In the UK alone there are more than 685,000 people with significant sight loss as a consequence of late-stage AMD and with an ageing world population, AMD cases are expected to double by 2040.
We will be joined by a multidisciplinary faculty of speakers, including people with AMD, their carers and relatives, expert clinicians and researchers to review and discuss current and future approaches to diagnosis and treatment of AMD in the light of an increased understanding of the biology, genetics and epidemiology.
What will you learn?
By attending this meeting, you will have the opportunity to:
About Medicine and Me
Medicine and Me meetings aim to provide an outline of current best practice and future updates of important conditions and to give direct voice to patients and their carers and enable them to discuss their concerns and reflections on the impact of diagnosis, investigation and management.
Physicians and surgeons and indeed all healthcare professionals continue to learn from and be inspired to greater efforts to improve care by hearing directly from patients.
Join in the conversation online
Follow us on Twitter: @RoySocMed
Dr Fiona Moss, Dean, Royal Society of Medicine
Dr Wen Hwa Lee, Chief Executive, Action on Age Related Macular Degeneration
To be confirmed
Ms Dawn Sims, Consultant Ophthalmologist, Moorfields Eye Hospital NHS Foundation Trust
Dr Wen Hwa Lee
Dr Pearse Keane, Associate Professor, University College London Instiute of Ophthalmology, Faculty of Brain Science
Panel discussion facilitated by Mr Beng Ong, Specialist Registrar, Western Eye Hospital
Panel: Professor Alastair Denniston, Honorary Professor, Institute of inflammation and aging, Univeristy of Birmingham and Consultant Ophthalmologist, University Hospitals Birmingham and Natalie Banner, Policy Adviser, Wellcome Trust
Royal Society of Medicine, 1 Wimpole St, Marylebone, London, W1G 0AE, United Kingdom
